Search Results 521-530 of 16723 for CLL
-
... CLL/SLL. For CLL/SLL, patients must have received prior therapies, namely a BTK inhibitor or BCL-2 inhibitor. These patients may or may not have received ...
-
Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...
-
Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...
-
In other blood cancers, such as lymphoma and chronic lymphocytic leukemia, the response rates for treatment with CAR-T cell therapy remain low. To improve ...
-
Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. Mayo Clin ...
-
Chronic lymphocytic leukemia; Multiple myeloma; Myeloproliferative diseases; Medical complications of hematological malignancies (e.g., neutropenic fever) ...
-
Relapsed, refractory follicular lymphoma; Relapsed, refractory multiple myeloma; Other types of cancer and medical conditions undergoing clinical studies. If ...
-
In general, causes of cancer fatigue may include: The cancer itself. Cancer treatment. Chronic pain. Emotions, such as feeling anxious, distressed, or depressed ...
-
Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...
-
... chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor. Haematologica 2020 Nov 1; 105 (11):2675-2678 Epub 2020 Nov 01